<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Cancer Urology</journal-id><journal-title-group><journal-title xml:lang="en">Cancer Urology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкоурология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9776</issn><issn publication-format="electronic">1996-1812</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">273</article-id><article-id pub-id-type="doi">10.17650/1726-9776-2009-5-2-61-64</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ МОЧЕПОЛОВОЙ СИСТЕМЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">THE PROGNOSTIC AND DIAGNOSTIC VALUE OF REPEATED TRANSRECTAL PROSTATE SATURATION BIOPSY</article-title><trans-title-group xml:lang="ru"><trans-title>ПРОГНОСТИЧЕСКАЯ И ДИАГНОСТИЧЕСКАЯ ЦЕННОСТЬ ПОВТОРНОЙ САТУРАЦИОННОЙ БИОПСИИ ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kurdzhiev</surname><given-names>M. A.</given-names></name><name xml:lang="ru"><surname>Курджиев</surname><given-names>М. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>Кафедра урологии</p></bio><email>mkurd@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Govorov</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Говоров</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>Кафедра урологии</p></bio><email>mkurd@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kovylina</surname><given-names>M. V.</given-names></name><name xml:lang="ru"><surname>Ковылина</surname><given-names>М. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>Кафедра урологии</p></bio><email>mkurd@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pushkar</surname><given-names>D. Yu.</given-names></name><name xml:lang="ru"><surname>Пушкарь</surname><given-names>Д. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>Кафедра урологии</p></bio><email>mkurd@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Department of Urology, Moscow State University of Medicine and Dentistry</institution></aff><aff><institution xml:lang="ru">МГМСУ</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2009-06-30" publication-format="electronic"><day>30</day><month>06</month><year>2009</year></pub-date><volume>5</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>61</fpage><lpage>64</lpage><history><date date-type="received" iso-8601-date="2014-08-04"><day>04</day><month>08</month><year>2014</year></date><date date-type="accepted" iso-8601-date="2014-08-04"><day>04</day><month>08</month><year>2014</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncourology.abvpress.ru/oncur/article/view/273">https://oncourology.abvpress.ru/oncur/article/view/273</self-uri><abstract xml:lang="en"><p><bold>Objective: </bold>to determine the rate of prostate cancer (PC) development after repeated transrectal saturation prostate biopsy (RTRSPB), to study the characteristics of diagnosed tumors, and to estimate their clinical significance from the data of radical retropubic prostatectomy (RRP).</p><p><bold>Materials and methods</bold>. The results of RTRSPB were analyzed in 226 patients with a later evaluation of a tumor from the results of RRP. All the patients underwent at least 2 prostate biopsies (mean 2.4). The average number of biopsy cores was 26.7 (range 24—30). The average value of total prostate-specific antigen before saturation biopsy was 7.5 (range 7.5 to 28.6) ng/ml. The mean age of patients was 62 years (range 53 to 70).  </p><p><bold>Results</bold>. PC was diagnosed in 14.6% of cases (33/226). An isolated lesion of the prostatic transition zone was in 12.1% of cases. If this zone had been excluded from the biopsy scheme, the detection rate of PC during saturation biopsy should be reduced by 13.8%. Better PC detectability during repeated saturation biopsy generally occurred due to the localized forms of the disease (93.3%). The agreement of Gleason tumor grading in the biopsy and prostatectomy specimens was noted in 66.7% of cases.</p><p><bold>Conclusion</bold>. Saturation biopsy allows prediction of a pathological stage of PC, Gleason grade of a tumor and its site localization with a greater probability. Most tumors detectable by saturation biopsy were clinically significant, which makes it possible to recommend RTRSPB to some cohort of high PC-risk patients </p></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>prostate cancer</kwd><kwd>diagnostics</kwd><kwd>secondary saturational biopsy</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>рак предстательной железы</kwd><kwd>диагностика</kwd><kwd>повторная сатурационная биопсия</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Borboroglu P.G., Comer S.W., Riffenburgh. R.H. et al. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol 2000;163(1):158—62.</mixed-citation><mixed-citation xml:lang="ru">Borboroglu P.G., Comer S.W., Riffenburgh. R.H. et al. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol 2000;163(1):158—62.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Fleshner N., Klotz L. Role of «saturation biopsy» in the detection of prostate cancer among difficult diagnostic cases. Urology 2002;60:93—7.</mixed-citation><mixed-citation xml:lang="ru">Fleshner N., Klotz L. Role of «saturation biopsy» in the detection of prostate cancer among difficult diagnostic cases. Urology 2002;60:93—7.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Patel A.R., Jones J.S., Rabets J. et al. Parasagittal biopsies add minimal information in repeat saturation prostate biopsy. Urology 2004;63:87—9.</mixed-citation><mixed-citation xml:lang="ru">Patel A.R., Jones J.S., Rabets J. et al. Parasagittal biopsies add minimal information in repeat saturation prostate biopsy. Urology 2004;63:87—9.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Rabets J.C., Jones J.S., Patel A. et al. Prostate cancer detection with office based saturation biopsy in a repeat biopsy popula- tion. J Urol 2004;172:94—7.</mixed-citation><mixed-citation xml:lang="ru">Rabets J.C., Jones J.S., Patel A. et al. Prostate cancer detection with office based saturation biopsy in a repeat biopsy popula- tion. J Urol 2004;172:94—7.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Stewart C.S., Leibovich B.C., Weaver A.L. et al. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001;66(1):86—92.</mixed-citation><mixed-citation xml:lang="ru">Stewart C.S., Leibovich B.C., Weaver A.L. et al. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001;66(1):86—92.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Walz J., Graefen M., Chun F. et al. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur Urol 2006;50(3): 498—505.</mixed-citation><mixed-citation xml:lang="ru">Walz J., Graefen M., Chun F. et al. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur Urol 2006;50(3): 498—505.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
